4-aminobenzamide has been researched along with Innate Inflammatory Response in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, AF; Ali, AA; El-Bassossy, HM; El-Maraghy, NN; Zakaria, EM | 1 |
1 other study(ies) available for 4-aminobenzamide and Innate Inflammatory Response
| Article | Year |
|---|---|
PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis.
Topics: Animals; Benzamides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diet, High-Fat; Fibrosis; Inflammation; Male; NF-kappa B; Oxidative Stress; para-Aminobenzoates; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Streptozocin; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2017 |